Primary nephrotic syndrome in adults is characterized by severe proteinuria and hypoalbuminemia. This was the first clinical trial to test rituximab in adult-onset frequently relapsing nephrotic ...

Relapsing-remitting multiple sclerosis (MS) is commonly treated with parenteral drugs that can lead to adverse events and poor adherence. Three phase 3 randomized trials evaluated the efficacy and ...

At Adult & Teen Challenge Northeastern Wisconsin, your road to recovery is within reach. Helping individuals attain freedom from chemical addictions and other life-controlling problems by addressing ...

When my daughter relapsed after six years of sobriety, it took her less than five months to lose everything she had worked so hard for: her job, her savings, her good credit rating, and—most ...

Rituximab (Rituxan) prevented relapse in patients with adult-onset frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS), a randomized trial showed. Among 66 ...